Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

Over the last decade, extensive studies have been made to understand the role played by the mammalian target of rapamycin (mTOR) in cancer. Knowledge in this field has been gained from discoveries in basic research as well as from observations made in patients treated with allosteric mTOR inhibitors...

Full description

Bibliographic Details
Main Authors: Olivier Dormond, Nicolas Demartines, Anne Dormond-Meuwly, Marc Dufour
Format: Article
Language:English
Published: MDPI AG 2011-05-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/3/2/2478/